Metformin Zentiva (Metformin Hydrochloride)

Metformin Hydrochloride works primarily by inhibiting hepatic glucose production and enhancing peripheral insulin sensitivity. It activates the enzyme AMP‑activated protein kinase (AMPK), which regulates carbohydrate and lipid metabolism, leading to reduced circulating glucose without stimulating insulin secretion.

The appropriate dose of Metformin Zentiva is determined by the prescribing healthcare professional based on individual patient factors such as renal function, age, and glycaemic response. Dosage adjustments are made during treatment to achieve optimal blood glucose control while minimizing side effects.

Safety of Metformin Zentiva in pregnancy or while breastfeeding should be evaluated by a qualified clinician. Current guidelines suggest it may be continued in certain cases of gestational diabetes, but the decision must weigh potential benefits against any possible risks to the fetus or infant.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin is a first‑line therapy for type 2 diabetes and differs from sulfonylureas, DPP‑4 inhibitors or SGLT2 inhibitors in its mechanism, safety profile, and lack of weight gain. It is generally well‑tolerated, inexpensive, and does not cause hypoglycaemia when used alone, making it a preferred initial option.

Metformin Zentiva should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Metformin Zentiva is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or conditions causing hypoxia. Prompt medical attention is required if symptoms such as unexplained fatigue, rapid breathing, or abdominal pain develop.

Metformin Zentiva is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those receiving radiographic contrast studies without adequate renal protection.